Search

Reports continually highlight the disparities between Black and white Americans in completing treatment for curable lung cancer and breast cancer. Disproportionately, African Americans are less likely to complete treatment, resulting in a higher rate of deaths. Researchers designed a quality improvement trial to examine potential interventions. Using data from 2007 to 2012, the researchers established...

The international prevalence of depression in patients with cervical cancer is high. This cross-sectional study, published in PLOS ONE, examines the factors associated with depression and a worse quality of life in patients with cervical cancer.  The study was conducted at a gynecologic oncology clinic affiliated with a university hospital in Thailand. A total of 200 patients...

Prostate cancer disparities have been well documented, and this study analyzes the way they manifest in the emotional and psychosocial lives of patients who have already undergone treatment, as well as their partners. Disparities in prostate cancer outcomes are caused by a variety of factors and result in a variety of different effects, including effects...

WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Spironolactone is not independently associated with increased breast cancer recurrence, according to a study published in the October issue of the Journal of the American Academy of Dermatology. Chapman Wei, from the George Washington University in Washington, D.C., and colleagues used the Humana Insurance database to identify breast...

A center-based cardiac rehabilitation program has greater adherence and satisfaction rates compared to community-based exercise training administered to cancer survivors with cardiovascular risk, according to this study. Both cardiovascular mortality and cardiovascular risk factors pose a significant burden on healthcare. A randomized controlled trial assessed the adherence, safety, and satisfaction of a center-based cardiac rehabilitation...

Triple-negative breast cancer patients treated with immune checkpoint inhibitors may experience a greater antitumoral immune response, according to a recent literature review. Immunotherapy, especially immune checkpoint inhibitors (ICIs), has revolutionized solid tumor malignancy treatment. ICIs target immunosuppressive receptors such as programmed cell death ligand 1 (PD-L1), programmed cell death 1 (PD-1), and cytotoxic T-lymphocyte-associated protein...

Obesity is a risk factor for cancer recurrence in resected hormone-sensitive breast cancer patients undergoing adjuvant chemotherapy with aromatase inhibitors, according to a recent study. Aromatase inhibitors (AIs) are extensively used for treating hormone-sensitive breast cancer (BC). In post-menopause, estrogen is mainly formed in the adipose tissue via aromatase-mediated androgen conversion, which might impair the...

Many lives could be saved if all patients were given equal access to lung cancer screening. Lung cancer incidence rates, treatment, and outcomes vary based on race, ethnicity, and sex. Previous research has identified disparities that result in worse patient outcomes across populations. Lung cancer screening has the potential to lower the mortality rate for...

The research team of The Framingham Study sought to examine the relationship between bone mass and the risk of prostate cancer. They hypothesized bone mass might be a potential biological marker for cumulative exposure to androgens as well as calcium intake. The researchers questioned if individuals with high bone mass might have an increased risk...

In a study published in JAMA Network Open, a team of researchers analyzed the geographic distribution of prostate cancer cases by race. They note that it has been well established that there are racial disparities in prostate cancer mortality rates. However, how these disparities are distributed geographically is not as well understood.  The cohort of men...